A total of 5,784 patent applications remained subject to invention secrecy orders at the end of Fiscal Year 17, according to new data provided by the US Patent and Trademark Office.
The secrecy orders, issued under the Invention Secrecy Act of 1951, restrict disclosure of patent applications considered to be “detrimental to national security” if published.
That total number was up slightly from the 5,680 secrecy orders that were in effect a year earlier.
Most existing patent secrecy orders are renewed year after year.
In FY17, there were 132 new secrecy orders that were imposed, and 28 existing orders that were rescinded, according to the US PTO data. There were 39 new “John Doe” orders imposed on private inventors who sought to patent inventions in which the government has no property interest.
Most invention secrecy applies to inventions involving technology relevant to military applications, but the full scope of the invention secrecy program is not described in public documents.
While the U.S. has made significant advancements and remained a global leader in biotechnology over the past decade, the next four years will be critical in determining whether it can sustain that leadership.
As the efficacy of environmental laws has waned, so has their durability. What was once a broadly shared goal – protecting Americans from environmental harm – is now a political football, with rules that whipsaw back and forth depending on who’s in charge.
It takes the average person over 9 hours and costs $160 to file taxes each year. IRS Direct File meant it didn’t have to.
It’s paramount to balance both innovation capabilities and risk as we work towards ensuring that the U.S. bioeconomy is a priority area for both the Nation and for National Security.